Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Burkitt Lymphoma 2Oropharyngeal Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Biphenotypic, Acute 1Cranial Nerve Diseases 1

Interventions

Cisplatin 14Radiotherapy, Intensity-Modulated 12pembrolizumab 7Radiotherapy 7Magnetic Resonance Spectroscopy 7Specimen Handling 6Platinum 6Carboplatin 6Radiation 51,2-diaminocyclohexaneplatinum II citrate 5Taxes 3Surveys and Questionnaires 3Paclitaxel 3Nivolumab 3Fluorodeoxyglucose F18 3Biopsy 3durvalumab 2Drug Therapy 2prednylidene 1peposertib 1niraparib 1exifone 1entinostat 1dostarlimab 1deltacortene 1dehydroftorafur 1cemiplimab 1bintrafusp alfa protein, human 1atezolizumab 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Oropharyngeal Neoplasms × exifone × Clear all
NCT04151082 2026-01-13

High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
35 enrolled
Head & Neck

Cranial Nerve Diseases, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡